Unlock France
Surpassing conventional models to establish your ‘Exploitant’ Subsidiary.
Establishing a commercial subsidiary in France is a time-consuming and resource-intensive process that can take up to 18 months.
It demands substantial local expertise, internal resource allocation, and local recruitment, even for part-time roles, to set-up and organize an ANSM-authorized Exploitant structure.
Biopharmaceutical companies with little or no initial presence in France are seeking customized solutions to rapidly establish their own Exploitant subsidiary for a swift business start, particularly to accelerate launch of their first product through an early access program.
Unlock France
Cutting 18 months from standard timeline for establishing an Exploitant subsidiary
We offer biopharmaceutical companies a unique and efficient pathway to market entry in France.
A ready-to-operate asset is provided, along with professional support and integration services.
This approach can save up to 18 months or more of setup time, enabling a focus on the core business of developing innovative treatments.
In summary, we offer :
- Acquisition of a PlugNPlay authorized Exploitant asset.
- Provision of team to operate the acquired Exploitant structure and manage Exploitant operations until the biotech team is in place.